September 29, 2006
IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for our customers who have established product allocations with us. Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.
From HHS
Statement by Mike Leavitt Secretary of Health and Human Services On the International Partnership on Avian and Pandemic Influenza, United Nations General Assembly  LINK...

From Sanofi Pasteur
Sanofi Pasteur Broadens Pandemic Preparedness with First Clinical Trial of Novel Cell Based H7N1 Vaccine   LINK...

From Public Hospital Pharmacy Coalition (PHPC)
Hospitals Struggle to Access Key Blood Products at Affordable Prices LINK...

From Consorta
Consorta Launches National Healthcare Supply Chain Magazine LINK...

 

 
FFF's Marlene Lovig Presented the Consorta Above and Beyond Award

FFF Enterprises is pleased to announce that Marlene Lovig, director of sales operations, has been presented the Consorta Above and Beyond Award.

Consorta, a GPO partner of FFF's, recognized that the responsiveness of their supplier representatives and company teams has greatly contributed to Consorta's success. The GPO wanted to acknowledge those who provide distinguished service, and created an awards program to do so: The Consorta Supplier Performance Awards were presented at the 2006 Annual Resource Management Conference & Exhibition. Consorta’s contracting and account directors and managers select the honorees, who are both corporations and individuals.

Consorta presented the Above and Beyond Award to Marlene because she regularly goes well beyond expected service parameters to support Consorta’s members and staff.

“I really appreciate Consorta’s recognition of our commitment to its members,” said Marlene. “While the award was presented to me, it is really a team effort. Everyone worked hard to meet Consorta’s needs, including our Xtreme Team, our Wow! Customer Care representatives and a key member of this initiative, our vice president of national accounts, Whitney Stuart.

"With the great people we have at FFF, I am always confident in my ability to say to Consorta 'Yes, we can certainly take care of that,' because I knew without a doubt we can make it happen.”

Please join FFF in congratulating Marlene. She can be reached at 800-843-7477 or at mlovig@fffenterprises.com .
 
Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.



Physicians – Help Improve Immune Deficiency Diagnosis!
Please encourage your primary immune deficient patients to take the STRIDE survey. They can access the survey through www.igliving.com.

Immunologist Charlotte Cunningham-Rundles, MD, PhD, has seen the damaging effects of the struggle many patients have obtaining proper diagnoses for their immune deficiency diseases.

“There are more than 100 known immune defects, but the overall clinical presentation, the illnesses that appear, and the immunologic abnormalities present in each are very different,” Cunningham-Rundles explained. “While these diseases are believed to be present in all populations, the diagnosis of primary immune deficiency varies considerably from one country to the next, and in the United States, even from one state to the next. We think this results from under-diagnosis and delayed diagnosis, which leads to increased morbidity and higher medical costs; in many cases the delay results in increased mortality.”

In response to this problem, Cunningham-Rundles and some colleagues applied for and received a National Institutes of Health grant to conduct a study call STRIDE, Study Targeting Recognition of Immune Deficiency and Evaluation. The hypothesis of STRIDE is that undiagnosed patients can be identified in large hospital or insurance populations, by using a newly devised computer scoring program to evaluate diagnoses associated with immune deficiencies.

“At Mount Sinai Hospital, we used the computer algorithm to find patients who had two or more significant illnesses suggestive of immunodeficiency, without other diagnoses leading to these conditions,” Cunningham-Rundles recounted. “When we tested a group of these patients, we verified that immune defects were present in 35 percent. We are continuing our program at this hospital and at affiliated hospitals in the New York area, and we are seeking to extend this to additional hospitals.”

For more information about implementing the STRIDE algorithm at your hospital, please contact 212-659-9268.

The STRIDE study also includes an important outreach program to solicit information directly from patients. One method of doing this is through an electronic survey. The survey will help identify what medical problems are important to patients and what events led to their correct diagnoses.

“We need as many patients as we can possibly reach to take the survey,” said Cunningham-Rundles. “Their input is a very important part of our research, which will ultimately help improve evaluation and diagnosis of immune deficiencies.”
Visit fffenterprises.com
BioSupply Trends is published by FFF Enterprises, the nation's most trusted distributor of biopharmaceuticals, plasma products and vaccines. FFF Enterprises is accelerating the availability of products, from development to delivery. Click here to contact FFF Enterprises or call 800-843-7477.

I want to receive BioSupply Trends
I want to stop receiving BioSupply Trends
I want to report technical trouble with BioSupply Trends
©2006 FFF Enterprises Inc.
Top of Page